Literature DB >> 14651808

Leukemia inhibitory factor promotes recovery of locomotor function following spinal cord injury in the mouse.

Da Wei Zang1, Surindar S Cheema.   

Abstract

We describe an easy, minimal, rapid, and reproducible model of mouse spinal cord injury (SCI) that results in permanent paralysis involving one hind limb. We used this model to evaluate whether the paralysis can be prevented using two known neuroprotective drugs, namely leukemia inhibitory factor (LIF) and minocycline (MIN). Mice in the control vehicle (VEH) and MIN groups with SCI had negligible recovery of locomotor behavior. In contrast, the LIF groups showed a statistically significant improvement in locomotor behavior. Maximal recovery was observed when LIF was administered 2, 8, and 24 h after lesion, while no significant recovery was observed when LIF treatment commenced 1 week after the lesion. Unbiased stereological estimates revealed significantly higher numbers of myelinated axons below the lesion in the maximal recovery LIF groups. We conclude that LIF may be a useful treatment for recovery from paralysis after SCI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651808     DOI: 10.1089/089771503770802880

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  10 in total

Review 1.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

2.  Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice.

Authors:  Mengzhou Xue; Elena I Mikliaeva; Steve Casha; David Zygun; Andrew Demchuk; V Wee Yong
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

3.  Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.

Authors:  Benjamin E Deverman; Paul H Patterson
Journal:  J Neurosci       Date:  2012-02-08       Impact factor: 6.167

4.  Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF.

Authors:  Chuanhui Yu; Abba J Kastin; Hong Tu; Weihong Pan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

5.  Effect of leukemia inhibitory factor on the myelinogenic ability of Schwann-like cells induced from human adipose-derived stem cells.

Authors:  Shahnaz Razavi; Mohammad Mardani; Mohammad Kazemi; Ebrahim Esfandiari; Manizheh Narimani; Abolghasem Esmaeili; Nafiseh Ahmadi
Journal:  Cell Mol Neurobiol       Date:  2012-12-05       Impact factor: 5.046

6.  Anatomical and functional outcomes following a precise, graded, dorsal laceration spinal cord injury in C57BL/6 mice.

Authors:  Rachel L Hill; Yi Ping Zhang; Darlene A Burke; William H Devries; Yongjie Zhang; David S K Magnuson; Scott R Whittemore; Christopher B Shields
Journal:  J Neurotrauma       Date:  2009-01       Impact factor: 5.269

7.  Evaluating the role of IL-11, a novel cytokine in the IL-6 family, in a mouse model of spinal cord injury.

Authors:  Newton Cho; Dung H Nguyen; Kajana Satkunendrarajah; Donald R Branch; Michael G Fehlings
Journal:  J Neuroinflammation       Date:  2012-06-20       Impact factor: 8.322

8.  Effects of leukemia inhibitory factor and basic fibroblast growth factor on free radicals and endogenous stem cell proliferation in a mouse model of cerebral infarction.

Authors:  Weihui Huang; Yadan Li; Yufeng Lin; Xue Ye; Dawei Zang
Journal:  Neural Regen Res       Date:  2012-07-05       Impact factor: 5.135

9.  The neuron regrowth is associated with the proliferation of neural precursor cells after leukemia inhibitory factor administration following spinal cord injury in mice.

Authors:  Yubo Li; Dawei Zang
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

10.  LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells.

Authors:  Hye Jeong Lee; Jung Ok Lee; Yong Woo Lee; Shin Ae Kim; Il Hyeok Seo; Jeong Ah Han; Min Ju Kang; Su Jin Kim; Yun-Ho Cho; Joong-Jean Park; Jong-Il Choi; Sun Hwa Park; Hyeon Soo Kim
Journal:  Int J Neuropsychopharmacol       Date:  2019-06-03       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.